Written answers
Thursday, 20 October 2022
Department of Health
Medicinal Products
John McGuinness (Carlow-Kilkenny, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
333. To ask the Minister for Health if the drug plaquenil will be approved for use in the case of a person (details supplied); and if he will make a statement on the matter. [52558/22]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The general scheme of the Patient Safety (Licensing) Bill - which will introduce a licensing requirement for hospitals, public and private, and certain designated high-risk activities in the community - was approved by Government on the 12th of December 2017; it underwent Pre-Legislative Scrutiny at the Oireachtas Joint Committee of Health on the 13th of June 2018; and it is currently with the Attorney General’s Office for drafting.
The Patient Safety (Licensing) Bill is part of a suite of measures to improve patient safety including the Patient Safety (Notifiable Patient Safety Incidents) Bill. Currently the Department is progressing the Patient Safety (Notifiable Patient Safety Incidents) Bill, which will provide the legislative framework for the extension of the Health Information Quality Authority's regulatory remit to private hospitals. This Bill also includes provisions for the establishment of a legislative framework for mandatory open disclosure and reporting of designated serious patient safety incidents and, the provision of certain legislative protections for the conduct of clinical audit against explicit clinical standards on a national basis. It is part of the current Programme for Government, was introduced into Dáil Éireann on the 12th of December 2019, passed Committee Stage on the 10th of March 2022 and is due to go to Report and Final Stages in the Autumn legislative session.
No comments